欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0829/001
药品名称CitraFleet Powder for oral solution
活性成分
    • sodium picosulfate 0.01 g
    • magnesium oxide 3.5 g
    • citric acid monohydrate 10.97 g
剂型Powder for oral solution
上市许可持有人Casen-Recordati S.L., Autovia De Logrono, km. 13,300, 50180 Utebo (Zaragoza), Spain
参考成员国 - 产品名称Ireland (IE)
PA2028/002/001
互认成员国 - 产品名称
    • Cyprus (CY)
      CITRAFLEET
    • Estonia (EE)
      CITRAFLEET
    • Malta (MT)
      CitraFleet Powder for Oral Solution 10mg/3.5g/10.97g
    • Liechtenstein (LI)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Slovenia (SI)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Hungary (HU)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Latvia (LV)
    • Croatia (HR)
    • Lithuania (LT)
      CitraFleet 0,01 g/3,5 g/10,97 g milteliai geriamajam tirpalui paketėlyje
    • Bulgaria (BG)
      CitraFleet
许可日期2008/04/05
最近更新日期2024/06/26
药物ATC编码
    • A06AB56 senna glycosides, combinations
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase